MDL 3094 - GLP-1 RAS PRODUCTS LIABILITY LITIGATION History: 2025: On May 14, 2025 , there will be a Rule 702 evidentiary hearing to determine the types of expert testimonies that will be accepted at the GLP-1 trials
Wegovy pill oral semaglutide 25 mg once daily becomes the first GLP 1 pill approved for chronic weight management in the US
This includes: Prescription Medications: Ozempic (semaglutide), other GLP-1 medications (like compounded semaglutide, oral semaglutide, compounded tirzepatide, oral tirzepatide, Mounjaro, Zepbound, Wegovy), insulin, oral diabetes medications, blood thinners, heart medications, etc
John Sharretts, the director of the Division of Diabetes, Lipid Disorders, and Obesity at the FDA's Center for Drug Evaluation and Research, said in a release